Peter C K Leung Selected Research

iturelix (Antide)

1/2016	Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor are expressed at tubal ectopic pregnancy implantation sites.
3/2006	Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter C K Leung Research Topics

Disease

57	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 05/2002
50	Neoplasms (Cancer) 01/2022 - 03/2003
12	Endometrial Neoplasms (Endometrial Cancer) 10/2019 - 06/2004
12	Carcinoma (Carcinomatosis) 01/2015 - 10/2005
10	Ovarian Epithelial Carcinoma 02/2015 - 10/2003
7	Neoplasm Metastasis (Metastasis) 10/2015 - 04/2006
6	Pre-Eclampsia (Preeclampsia) 01/2021 - 10/2004
6	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2003
5	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 06/2019 - 08/2012
4	Choriocarcinoma 05/2019 - 07/2002
4	Carcinogenesis 07/2010 - 01/2003
3	Endometriosis 10/2020 - 09/2011
3	Ovarian Hyperstimulation Syndrome 01/2020 - 02/2003
3	Granulosa Cell Tumor 01/2014 - 01/2013
2	Body Weight (Weight, Body) 11/2021 - 07/2004
2	Disease Progression 10/2020 - 07/2018
2	Pathologic Processes 01/2020 - 06/2016
2	Insulin Resistance 06/2019 - 01/2019
2	Obesity 01/2019 - 10/2009
2	Inflammation (Inflammations) 01/2018 - 08/2006
2	Infertility (Sterility) 01/2018 - 12/2016
2	Hyperandrogenism 02/2017 - 08/2012
2	Ascites 01/2013 - 04/2010
2	Infections 10/2010 - 03/2008
2	Adenocarcinoma 04/2010 - 02/2009
2	Medulloblastoma 11/2005 - 02/2005
1	Wilms Tumor (Wilm's Tumor) 12/2021
1	Hypertriglyceridemia 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Hyperlipidemias (Hyperlipidemia) 11/2021

Drug/Important Bio-Agent (IBA)

24	Cadherins (E-Cadherin)IBA 01/2019 - 05/2007
22	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 02/2003
13	Epidermal Growth Factor (EGF)IBA 10/2020 - 02/2009
13	His(5)-Trp(7)-Tyr(8)- LHRHIBA 03/2011 - 04/2003
11	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2003
11	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2016 - 07/2002
10	Hormones (Hormone)IBA 01/2016 - 10/2003
9	ErbB Receptors (EGF Receptor)IBA 05/2019 - 10/2009
8	LigandsIBA 12/2016 - 04/2013
8	Messenger RNA (mRNA)IBA 01/2015 - 06/2006
8	GonadotropinsIBA 07/2010 - 04/2003
7	Estrogens (Estrogen)FDA Link 01/2020 - 08/2003
5	LeptinIBA 11/2021 - 01/2005
5	Estrogen ReceptorsIBA 01/2020 - 12/2004
5	Biological ProductsIBA 05/2016 - 03/2005
5	EnzymesIBA 12/2013 - 11/2008
4	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 01/2022 - 05/2010
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 05/2016
4	AmphiregulinIBA 05/2019 - 11/2014
4	Small Interfering RNA (siRNA)IBA 01/2017 - 02/2011
4	IntegrinsIBA 01/2017 - 07/2012
4	Estrogen Receptor alphaIBA 11/2013 - 12/2003
4	p38 Mitogen-Activated Protein KinasesIBA 02/2013 - 06/2004
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2012 - 10/2003
4	Mitogen-Activated Protein KinasesIBA 08/2009 - 01/2005
4	SteroidsIBA 03/2008 - 04/2003
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2010
3	activin AIBA 01/2021 - 01/2014
3	Connexin 43 (Connexin43)IBA 01/2020 - 10/2015
3	Lithium ChlorideIBA 01/2018 - 03/2011
3	Luteinizing Hormone (Lutropin)FDA LinkGeneric 08/2017 - 06/2005
3	Metalloproteases (Metalloproteinases)IBA 04/2011 - 08/2006
3	Matrix Metalloproteinases (MMPs)IBA 03/2011 - 11/2006
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2011 - 04/2006
3	Peptide Hydrolases (Proteases)FDA Link 07/2010 - 04/2006
3	Glycoproteins (Glycoprotein)IBA 01/2010 - 05/2004
2	BetacellulinIBA 01/2020 - 05/2016
2	Glucose (Dextrose)FDA LinkGeneric 06/2019 - 02/2017
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018 - 08/2014
2	CytokinesIBA 01/2018 - 02/2007
2	MyostatinIBA 01/2018 - 11/2016
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2017 - 06/2016
2	Insulin-Like PeptidesIBA 02/2017 - 12/2012
2	somatotropin releasing hormone receptorIBA 01/2017 - 05/2010
2	activin BIBA 06/2016 - 10/2015
2	iturelix (Antide)IBA 01/2016 - 03/2006
2	Activins (Activin)IBA 10/2015 - 01/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2015 - 05/2015
2	Leptin ReceptorsIBA 03/2013 - 01/2005
2	Indicators and Reagents (Reagents)IBA 02/2013 - 05/2004
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2013 - 08/2010
2	matrigelIBA 08/2011 - 02/2011
2	CollagenIBA 05/2011 - 05/2004
2	ThrombospondinsIBA 04/2011 - 08/2006
2	GelatinIBA 07/2010 - 11/2006
2	Complementary DNA (cDNA)IBA 02/2009 - 09/2007
2	Progesterone FDA LinkGeneric 03/2008 - 02/2005
2	Transcription Factors (Transcription Factor)IBA 03/2008 - 05/2007
2	Pharmaceutical PreparationsIBA 03/2008 - 06/2007
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2008 - 08/2003
2	Protein Isoforms (Isoforms)IBA 03/2008 - 11/2006
2	Follicle Stimulating Hormone (Follitropin)FDA Link 04/2006 - 06/2005
2	Protein Kinases (Protein Kinase)IBA 03/2006 - 03/2005
2	FSH Receptors (FSH Receptor)IBA 11/2004 - 05/2002
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	UbiquitinIBA 12/2021
1	WT1 ProteinsIBA 12/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2021
1	LipidsIBA 11/2021

Therapy/Procedure

7	Therapeutics 07/2018 - 06/2004